chr21-30755197-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_181619.2(KRTAP21-1):c.182G>A(p.Gly61Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000297 in 1,614,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_181619.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRTAP21-1 | NM_181619.2 | c.182G>A | p.Gly61Asp | missense_variant | 1/1 | ENST00000335093.5 | NP_853650.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRTAP21-1 | ENST00000335093.5 | c.182G>A | p.Gly61Asp | missense_variant | 1/1 | 6 | NM_181619.2 | ENSP00000335566.3 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248974Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134788
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461876Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 8AN XY: 727236
GnomAD4 genome AF: 0.000158 AC: 24AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74422
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.182G>A (p.G61D) alteration is located in exon 1 (coding exon 1) of the KRTAP21-1 gene. This alteration results from a G to A substitution at nucleotide position 182, causing the glycine (G) at amino acid position 61 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at